New Directions In Cancer Treatment
This book brings together in one volume a large amount of information on the progress that is being made in developing novel and improved methods of cancer treatment. The first part of the book reviews areas such as: - physical treatment, including radiation therapy and hyperthermia; - chemotherapy, with particular interest in new drugs and methods of overcoming drug resistance; - biological approaches, including biological response modifiers, monoclonal antibodies and hormonal therapies; - and future approaches, such as the prevention of metastases, the induction of differentiation or even the utilization of the specific molecular lesions in cancer as a target for therapy. The second part deals with recent progress and future directions in particular types of cancer. The book is well referenced so as to serve as a base for more detailed exploration of any given topic. The dissemination of such new information aims to foster additional collaborative studies and possibly the development of new research protocols.
What people are saying - Write a review
We haven't found any reviews in the usual places.
New Approaches in Radiation Therapy
Past Present and Future
6 other sections not shown
ABMT Acad Sci USA activity acute adjuvant administration agents allogeneic amplification anticancer antigens antitumor approach autologous autologous bone marrow biochemical Biol biological bone marrow transplantation brain tumors breast cancer c-myc Cancer Res cell carcinoma cell lines cellular chromosome cisplatin Clin Oncol clinical trials compounds conjugates currently cyclophosphamide cytotoxic differentiation disease doxorubicin drug resistance effects efficacy enzyme estrogen evaluation gene growth factor high dose high-dose hormone human tumors hyperthermia immunotherapy immunotoxins increased induced infusion inhibit interferon irradiation kinase lesions leukemia levels lung lymphoma malignant melanoma melphalan metastatic methotrexate modality monoclonal antibodies Natl Acad Sci neoplasms neuroblastoma normal tissue oncogene Oncology ovarian cancer patients phase potential Proc Natl Acad prostate protein radiation therapy radiotherapy receptor recurrence regimens relapse remission renal cell carcinoma resection response rate role sarcoma sensitivity specific studies surgery surgical survival target therapeutic tion toxicity treatment tumor cells verapamil vitro vivo